Related Experiment Video

Updated: Jun 4, 2026

Paramyxoviruses for Tumor-targeted Immunomodulation: Design and Evaluation Ex Vivo
12:42

Paramyxoviruses for Tumor-targeted Immunomodulation: Design and Evaluation Ex Vivo

Published on: January 7, 2019

Oncolytic vaccinia virus for the treatment of cancer

Kilian Guse1, Vincenzo Cerullo, Akseli Hemminki

  • 1Baylor College of Medicine, Department of Human and Molecular Genetics, Houston, TX, USA.

Expert Opinion on Biological Therapy
|February 23, 2011
PubMed
Abstract

Insights

Vaccinia virus shows promise in cancer gene therapy, particularly as an oncolytic virus. The GM-CSF expressing vaccinia virus, JX-594, demonstrates strong clinical data, with a Phase III trial upcoming.

Area of Science:

  • Oncology
  • Virology
  • Gene Therapy

Background:

  • Gene therapy presents novel strategies for developing anticancer agents.
  • Vaccinia virus is a notable gene therapy vector, especially for oncolytic virus applications.

Purpose of the Study:

  • This review explores vaccinia virus applications in cancer therapy.
  • It focuses on vaccinia virus as a gene therapy vector, oncolytic virus, and in oncolysate generation.
  • Emphasis is placed on vaccinia as an oncolytic vector and combination therapies.

Main Methods:

  • Review of literature on vaccinia virus in cancer therapy.
  • Summary of achievements in gene therapy vector, oncolytic virus, and oncolysate applications.
  • Detailed review of GM-CSF expressing JX-594, including preclinical and clinical data.

Main Results:

  • Vaccinia virus exhibits significant potential in cancer gene therapy.
  • JX-594, a vaccinia virus, has shown promising preclinical and clinical results.
  • A Phase III trial for JX-594 in hepatocellular carcinoma is anticipated.

Conclusions:

  • Vaccinia virus holds substantial promise for cancer gene therapy, particularly as an oncolytic virus.
  • JX-594 has demonstrated encouraging preclinical and clinical outcomes.
  • Advancements position vaccinia virus as a key player in future cancer treatment strategies.

More Related Videos

A Simple and Efficient Approach to Construct Mutant Vaccinia Virus Vectors09:16

A Simple and Efficient Approach to Construct Mutant Vaccinia Virus Vectors

Published on: October 30, 2016

Transarterial Administration of Oncolytic Viruses for Locoregional Therapy of Orthotopic HCC in Rats08:55

Transarterial Administration of Oncolytic Viruses for Locoregional Therapy of Orthotopic HCC in Rats

Published on: April 15, 2016

Related Concept Videos

Cancer Vaccines01:30

Cancer Vaccines

Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Tumor Immunotherapy01:27

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
Cancer Therapies02:49

Cancer Therapies

Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
Cancer Therapies02:49

Cancer Therapies

Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...